Videos
Topical Therapy for Treating Squamous Cell Carcinoma in Situ
05/31/2023
In this interview, Dr Emily Ruiz discusses her session, “Pro and Con: Contentious Concepts,” at the 2023 ACMS Annual Meeting. She covered the topic, “Mohs vs Topical Therapy for Squamous Cell Carcinoma in Situ: Pro Topical Therapy.”
Emily Ruiz, MD, MPH, is an associate physician at the Mohs and Dermatologic Surgery Center of Brigham and Women’s Faulkner Hospital in Boston, MA. She is also an assistant professor of dermatology at Harvard Medical School in Boston, MA, and director of the High-Risk Skin Cancer Clinic at Dana Farber/Brigham and Women’s Hospital in Boston, MA.
Transcript coming soon!
Current Issue
October 2024
Volume 32
Issue 7
Subscribe
The Dermatologist Newsletter
